Figure 4: Schematic illustration of MSC mediated prodrug gene therapy for cancer. Mesenchymal stem/stromal cells engineered to express the yeast fused yCD-UPRT gene release tumor killing exosomes that in combination with 5-FU bystander effect are responsible for the high therapeutic efficacy of yCD-UPRT-AT-MSC/5-FC system.